Salomon & Ludwin’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Salomon & Ludwin's ONC Position: Q3 2026 in Review
Salomon & Ludwin held its BeOne Medicines (ONC) position steady in Q3 2026 at 2 shares worth $732. The position accounts for ﹤0.01% of the portfolio, ranked #1657.
Salomon & Ludwin first reported a position in ONC in Q1 2024 and has held it in 11 quarters since. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Salomon & Ludwin held 2 shares of BeOne Medicines worth $732 as of Q3 2026.
- Salomon & Ludwin left its BeOne Medicines share count unchanged in Q3 2026.
- BeOne Medicines made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1657 holding.
- Salomon & Ludwin first reported a position in BeOne Medicines in Q1 2024 and has held it in 11 quarters since.
- 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.